12


/ Press Releases
2017.08
TWi Pharmaceuticals, Inc. Comments on Oxtellar XR® Ruling
2017.08
TWi successfully launches generic Guanfacine Hydrochloride ER Tablet in TWi label
2017.06
TWi Confirms Patent Challenge Relating to Its Paragraph IV ANDA Filing for a Generic Equivalent to Tecfidera
2017.04
TWi Signed a Cooperation Agreement with Intech for US Inhalation Market
2017.02
TWi Confirms Patent Challenge Relating to Its Paragraph IV ANDA Filing for a Generic Equivalent to Axiron